Insider Trades32 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Sell | RAPP | Abraham Ceesay | Chief Executive Officer | 8,210 | $40.00 | $2.0B | -2.61% | +212.92% | $328.4K | -0.75% | 10b5-1 | Sell Now |
| Jun 30, 2026 | Sell | RAPP | Cheryl Gault | Chief Operating Officer | 10,000 | $41.58 | $2.0B | -2.61% | +212.92% | $415.8K | -1.60% | 10b5-1 | Sell Now |
| Jun 29, 2026 | Sell | RAPP | Abraham Ceesay | Chief Executive Officer | 8,220 | $39.83 | $2.0B | -2.61% | +212.92% | $327.4K | -0.74% | 10b5-1 | Sell Now |
| Apr 17, 2026 | Sell | RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | 20,225 | $39.99 | $2.0B | -2.61% | +212.92% | $808.8K | -7.58% | 10b5-1 | Sell Now |
| Apr 10, 2026 | Sell | RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | 19,865 | $35.03 | $2.0B | -2.61% | +212.92% | $695.8K | -2.34% | 10b5-1 | Sell Now |
| Apr 8, 2026 | Sell | RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | 360 | $34.90 | $2.0B | -2.61% | +212.92% | $12.6K | -0.13% | 10b5-1 | Sell Now |
| Mar 30, 2026 | Sell | RAPP | Cheryl Gault | Chief Operating Officer | 10,000 | $28.19 | $2.0B | -2.61% | +212.92% | $281.9K | -3.01% | 10b5-1 | Sell Now |
| Mar 25, 2026 | Sell | RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | 10,115 | $29.99 | $2.0B | -2.61% | +212.92% | $303.4K | -3.41% | 10b5-1 | Sell Now |
| Mar 5, 2026 | Sell | RAPP | Cheryl Gault | Chief Operating Officer | 2,014 | $28.93 | $2.0B | -2.61% | +212.92% | $58.3K | -1.17% | — | Sell Now |
| Feb 18, 2026 | Sell | RAPP | Abraham Ceesay | Chief Executive Officer | 10,916 | $29.35 | $2.0B | -2.61% | +212.92% | $320.4K | -0.93% | 10b5-1 | Sell Now |
| Feb 17, 2026 | Sell | RAPP | David Bredt | Chief Scientific Officer | 14,500 | $17.76 | $2.0B | -2.61% | +212.92% | $257.5K | -0.15% | 10b5-1 | Sell Now |
| Jan 20, 2026 | Sell | RAPP | Abraham Ceesay | Chief Executive Officer | 10,916 | $26.11 | $2.0B | -2.61% | +212.92% | $285.1K | -1.82% | 10b5-1 | Sell Now |
| Jan 15, 2026 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $26.84 | $2.0B | -2.61% | +212.92% | $228.1K | -1.06% | 10b5-1 | Sell Now |
| Dec 31, 2025 | Sell | RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | 2,840 | $30.05 | $2.0B | -2.61% | +212.92% | $85.3K | -0.95% | — | Sell Now |
| Dec 31, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 6,567 | $30.05 | $2.0B | -2.61% | +212.92% | $197.3K | -1.60% | — | Sell Now |
| Dec 17, 2025 | Sell | RAPP | Abraham Ceesay | Chief Executive Officer | 10,916 | $29.64 | $2.0B | -2.61% | +212.92% | $323.5K | -0.60% | 10b5-1 | Sell Now |
| Dec 15, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $30.02 | $2.0B | -2.61% | +212.92% | $255.1K | -1.07% | 10b5-1 | Sell Now |
| Nov 26, 2025 | Sell | RAPP | Cheryl Gault | Chief Operating Officer | 10,000 | $15.95 | $2.0B | -2.61% | +212.92% | $159.5K | +0.00% | 10b5-1 | Sell Now |
| Nov 17, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $25.19 | $2.0B | -2.61% | +212.92% | $214.1K | -1.04% | 10b5-1 | Sell Now |
| Nov 17, 2025 | Sell | RAPP | Abraham Ceesay | Chief Executive Officer | 10,916 | $25.20 | $2.0B | -2.61% | +212.92% | $275.0K | -0.88% | 10b5-1 | Sell Now |
| Oct 15, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $25.79 | $2.0B | -2.61% | +212.92% | $219.2K | -1.03% | 10b5-1 | Sell Now |
| Oct 15, 2025 | Sell | RAPP | Abraham Ceesay | Chief Executive Officer | 10,916 | $25.81 | $2.0B | -2.61% | +212.92% | $281.7K | -0.87% | 10b5-1 | Sell Now |
| Sep 17, 2025 | Sell | RAPP | Abraham Ceesay | Chief Executive Officer | 76,420 | $26.32 | $2.0B | -2.61% | +212.92% | $2.0M | -5.70% | 10b5-1 | Sell Now |
| Sep 15, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $24.19 | $2.0B | -2.61% | +212.92% | $205.6K | -1.00% | 10b5-1 | Sell Now |
| Sep 8, 2025 | Sell | RAPP | Cheryl Gault | Chief Operating Officer | 10,000 | $20.07 | $2.0B | -2.61% | +212.92% | $200.7K | +0.00% | 10b5-1 | Sell Now |
| Aug 15, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $15.00 | $2.0B | -2.61% | +212.92% | $127.5K | -0.99% | 10b5-1 | Sell Now |
| Jul 15, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $14.00 | $2.0B | -2.61% | +212.92% | $119.0K | -1.92% | 10b5-1 | Sell Now |
| Jun 16, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $11.00 | $2.0B | -2.61% | +212.92% | $93.5K | -1.88% | 10b5-1 | Sell Now |
| May 15, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $9.56 | $2.0B | -2.61% | +212.92% | $81.3K | -1.85% | 10b5-1 | Sell Now |
| Apr 15, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $9.57 | $2.0B | -2.61% | +212.92% | $81.3K | -1.81% | 10b5-1 | Sell Now |
| Mar 14, 2025 | Sell | RAPP | David Bredt | Chief Scientific Officer | 8,500 | $10.85 | $2.0B | -2.61% | +212.92% | $92.2K | -1.78% | 10b5-1 | Sell Now |
| Mar 12, 2025 | Buy | RAPP | Troy A. Ignelzi | Chief Financial Officer | 10,000 | $10.10 | $2.0B | -2.61% | +212.92% | $101.0K | +101.01% | — | Sell Now |